| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 143,683 | 139,087 | 122,296 | 157,688 | | Cost of Revenue |
-
|
-
|
-
| (399,253) | | | Gross Profit | 143,683 | 139,087 | 122,296 | 556,941 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 390,469 | 371,857 | 361,180 | 705,657 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,719 | 2,761 | 2,641 | 2,685 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (269,747) | (235,531) | (241,525) | (151,401) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 76,742 | 19,441 | (2,528) | 41,481 | | Earnings Before Interest And Taxes | (188,971) | (165,033) | (278,902) | (14,444) | | Interest Expense | 4,451 | 7,605 | 8,186 | 10,435 | | Income Before Tax | (193,422) | (172,638) | (287,088) | (24,879) | | Income Tax Expense | (3,116) | (1,308) | (407) | 115,496 | | Minority Interest |
-
|
-
|
-
| 286,106 | | | | Net Income From Continuing Ops | (133,753) | (171,330) | (286,681) | (140,375) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (190,306) | (171,330) | (286,681) | (140,375) | | Preferred Stock And Other Adjustments | 477,964 | (219,522) | 219,522 |
-
| | | Net Income Applicable To Common Shares | $287,658 | ($390,852) | ($67,159) | ($140,375) |
|
0.01% Nasdaq 
0.0184 (0.36%) 
Income Statement
